Lanadelumab: Solution for subcutaneous injection 300 mg in 2 mL; Takhzyro® Page last updated: 13 November 2020 Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1427KB) Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 145KB)